Technology Transfer Office

Transforming Our Discoveries Into Therapeutics

The Technology Transfer Office embodies the spirit of the National Jewish Health brand promise, Science Transforming Life®. We accelerate the development of basic scientific research toward clinical application by identifying and protecting the institution's intellectual property and facilitating business partnerships for technology development, licensing, and commercialization.

National Jewish Health currently has in its portfolio:

  • 215 active technologies developed from our research

  • 71 active U.S. patents protecting these technologies

  • 50 percent of those active US patents are licensed to biotechnology companies for the development of therapeutics consistent with the spirit of the National Jewish Health brand promise, Science Transforming Life®.

Additionally, in the 18 years since the Technology Transfer Office was created, National Jewish Health has:

  • executed 249 license agreements, of which 158 are still active;

  • executed a total of 2051 material transfer agreements; and

  • helped create 11 start-up companies.


Technologies from National Jewish Health

To browse a list of the technologies ready for licensing or further development, select one of the following:


Featured Technology: Novel TLR Inhibitors Prevent Respiratory Syncytial Virus Infection In Vivo


Contact Information

Emmanuel Hilaire, PhD
Phone: 303.398.1262

Susana B. Cestino Read, DVM, MBA
Licensing Associate
Phone: 303.398.1933

Stephanie Piersma, MLIS
Program Administrator
Phone: 303.398.1045

National Jewish Health
Technology Transfer Office
1400 Jackson St., M206
Denver, CO 80206
Fax: 303.270.2352

Bookmark and Share

Faculty by Research

The discoveries made in the laboratories at National Jewish Health have a profound impact on the understanding and treatment of human disease.

Browse our Faculty by Area of Research.